Page last updated: 2024-11-04

sulforaphane and Cholangiocellular Carcinoma

sulforaphane has been researched along with Cholangiocellular Carcinoma in 2 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tomooka, F1
Kaji, K1
Nishimura, N1
Kubo, T1
Iwai, S1
Shibamoto, A1
Suzuki, J1
Kitagawa, K1
Namisaki, T1
Akahane, T1
Mitoro, A1
Yoshiji, H1
Račkauskas, R1
Zhou, D1
Ūselis, S1
Strupas, K1
Herr, I1
Schemmer, P1

Other Studies

2 other studies available for sulforaphane and Cholangiocellular Carcinoma

ArticleYear
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity.
    Cells, 2023, 02-22, Volume: 12, Issue:5

    Topics: Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcin

2023
Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
    Oncology reports, 2017, Volume: 37, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Prolife

2017